Studies on prevention of obesity, metabolic syndrome, diabetes, cardiovascular diseases and cancer by tea

Chung Shu Yang, Hong Wang, Zachary Paul Sheridan

Research output: Contribution to journalReview article

21 Citations (Scopus)

Abstract

Tea, a popular beverage made from leaves of the plant Camellia sinensis, has been studied extensively in recent decades for its beneficial health effects in the prevention of obesity, metabolic syndrome, diabetes, cancer, and other diseases. Whereas these beneficial effects have been convincingly demonstrated in most laboratory studies, results from human studies have not been consistent. Some studies demonstrated that weight reduction, alleviation of metabolic syndrome and risk reduction in diabetes were only observed in individuals who consume 3–4 cups of tea (600–900 mg tea catechins) or more daily. This chapter reviews some of these studies, the possible mechanisms of actions of tea constituents, and the challenges in extrapolating laboratory studies to human situations.

Original languageEnglish (US)
Pages (from-to)1-13
Number of pages13
JournalJournal of Food and Drug Analysis
Volume26
Issue number1
DOIs
StatePublished - Jan 2018

Fingerprint

metabolic syndrome
Tea
tea
cardiovascular diseases
diabetes
obesity
Cardiovascular Diseases
Obesity
neoplasms
Neoplasms
Camellia sinensis
Plant Leaves
Catechin
risk reduction
Beverages
Risk Reduction Behavior
flavanols
beverages
Weight Loss
mechanism of action

All Science Journal Classification (ASJC) codes

  • Food Science
  • Pharmacology

Keywords

  • Cancer
  • Diabetes
  • Metabolic syndrome
  • Obesity
  • Polyphenols

Cite this

@article{83cd026f5a084083a00c70624e971601,
title = "Studies on prevention of obesity, metabolic syndrome, diabetes, cardiovascular diseases and cancer by tea",
abstract = "Tea, a popular beverage made from leaves of the plant Camellia sinensis, has been studied extensively in recent decades for its beneficial health effects in the prevention of obesity, metabolic syndrome, diabetes, cancer, and other diseases. Whereas these beneficial effects have been convincingly demonstrated in most laboratory studies, results from human studies have not been consistent. Some studies demonstrated that weight reduction, alleviation of metabolic syndrome and risk reduction in diabetes were only observed in individuals who consume 3–4 cups of tea (600–900 mg tea catechins) or more daily. This chapter reviews some of these studies, the possible mechanisms of actions of tea constituents, and the challenges in extrapolating laboratory studies to human situations.",
keywords = "Cancer, Diabetes, Metabolic syndrome, Obesity, Polyphenols",
author = "Yang, {Chung Shu} and Hong Wang and Sheridan, {Zachary Paul}",
year = "2018",
month = "1",
doi = "10.1016/j.jfda.2017.10.010",
language = "English (US)",
volume = "26",
pages = "1--13",
journal = "Journal of Food and Drug Analysis",
issn = "1021-9498",
publisher = "National Laboratories of Foods and Drugs",
number = "1",

}

Studies on prevention of obesity, metabolic syndrome, diabetes, cardiovascular diseases and cancer by tea. / Yang, Chung Shu; Wang, Hong; Sheridan, Zachary Paul.

In: Journal of Food and Drug Analysis, Vol. 26, No. 1, 01.2018, p. 1-13.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Studies on prevention of obesity, metabolic syndrome, diabetes, cardiovascular diseases and cancer by tea

AU - Yang, Chung Shu

AU - Wang, Hong

AU - Sheridan, Zachary Paul

PY - 2018/1

Y1 - 2018/1

N2 - Tea, a popular beverage made from leaves of the plant Camellia sinensis, has been studied extensively in recent decades for its beneficial health effects in the prevention of obesity, metabolic syndrome, diabetes, cancer, and other diseases. Whereas these beneficial effects have been convincingly demonstrated in most laboratory studies, results from human studies have not been consistent. Some studies demonstrated that weight reduction, alleviation of metabolic syndrome and risk reduction in diabetes were only observed in individuals who consume 3–4 cups of tea (600–900 mg tea catechins) or more daily. This chapter reviews some of these studies, the possible mechanisms of actions of tea constituents, and the challenges in extrapolating laboratory studies to human situations.

AB - Tea, a popular beverage made from leaves of the plant Camellia sinensis, has been studied extensively in recent decades for its beneficial health effects in the prevention of obesity, metabolic syndrome, diabetes, cancer, and other diseases. Whereas these beneficial effects have been convincingly demonstrated in most laboratory studies, results from human studies have not been consistent. Some studies demonstrated that weight reduction, alleviation of metabolic syndrome and risk reduction in diabetes were only observed in individuals who consume 3–4 cups of tea (600–900 mg tea catechins) or more daily. This chapter reviews some of these studies, the possible mechanisms of actions of tea constituents, and the challenges in extrapolating laboratory studies to human situations.

KW - Cancer

KW - Diabetes

KW - Metabolic syndrome

KW - Obesity

KW - Polyphenols

UR - http://www.scopus.com/inward/record.url?scp=85035787976&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85035787976&partnerID=8YFLogxK

U2 - 10.1016/j.jfda.2017.10.010

DO - 10.1016/j.jfda.2017.10.010

M3 - Review article

C2 - 29389543

AN - SCOPUS:85035787976

VL - 26

SP - 1

EP - 13

JO - Journal of Food and Drug Analysis

JF - Journal of Food and Drug Analysis

SN - 1021-9498

IS - 1

ER -